Status:

RECRUITING

Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases

Lead Sponsor:

University Hospital, Lille

Conditions:

Von Willebrand Diseases

Glanzmann Thrombasthenia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

In Willebrand disease, there is currently no test available to identify non-invasively patients with a high risk of bleeding from angiodysplasias The study propose to use a sublingual capillary bed an...

Eligibility Criteria

Inclusion

  • Adult patient with a significant form of von Willebrand disease (according to the inclusion criteria of the Willebrand Disease French Reference Center), a Glanzmann Thrombasthenia, a moderate to severe Haemophilia A or a woman carrying the hemophilia gene
  • Social insured patient

Exclusion

  • Minor patient
  • Refusal of consent
  • Person benefiting from a system of legal protection
  • Pregnant patient

Key Trial Info

Start Date :

May 24 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 24 2028

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT04119908

Start Date

May 24 2023

End Date

May 24 2028

Last Update

September 7 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU de Lille

Lille, Nord, France, 59000